[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61598]], camposKey:2045-2322 2020-01-01 Validation of a survival benefit estimator tool in a cohort of European kidney transplant recipients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61621]], camposKey:2077-0383 2019-01-01 Impact on outcomes across KDIGO-2012 AKI criteria according to baseline renal function00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=17252]], camposKey:1886-2845 2017-01-01 Correlaciones clínicas de los recuentos en sangre periférica de células T reguladoras en el post-trasplante renal8291, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=23321]], camposKey:1886-2845 2017-01-01 Evolución del metabolismo óseo-mineral y de la lesión vascular y ósea tras el trasplante renal6467, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61599]], camposKey:1932-6203 2017-01-01 Hypoglycemia following intravenous insulin plus glucose for hyperkalemia in patients with impaired renal function00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58798]], camposKey:0025-7753 2017-01-01 Peripheral blood regulatory T cell counts as a predictive biomarker for the outcome of kidney transplant: A systematic review523535, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=23320]], camposKey:1886-2845 2017-01-01 ¿Son los recuentos de células T reguladoras en sangre periférica un biomarcador predictivo y pronóstico para mejorar los resultados en el trasplante renal? Una revisión sistemática4056, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=23319]], camposKey:1886-2845 2015-01-01 Impacto del riesgo cardiovascular del donante-receptor en la supervivencia del injerto y receptor de trasplante renal cadáver. ¿De dónde venimos?, ¿hacia dónde vamos?5555, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61601]], camposKey:0211-6995 2014-01-01 Clinical, analytical and bioimpedance characteristics of persistently overhydrated haemodialysis patients
Características clínicas, analíticas y de bioimpedancia de los pacientes en hemodiálisis persistentemente hiperhidratados716723, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61602]], camposKey:0211-6995 2014-01-01 Sialadenitis por contraste422423, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61624]], camposKey:1121-8428 2013-01-01 Geographical variability of patient characteristics and treatment patterns affect outcomes for incident hemodialysis patients119128, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61620]], camposKey:0931-0509 2013-01-01 Impact of targeting Kt instead of Kt/V25952603, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61603]], camposKey:0211-6995 2012-01-01 Epidemiological study of 7316 patients on haemodialysis treated in FME clinics in Spain, using data from the EuCliD® database: Results from years 2009-2010743753, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=48847]], camposKey:1471-2350 2012-01-01 Genetic polymorphisms located in genes related to immune and inflammatory processes are associated with end-stage renal disease: a preliminary study580, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=48355]], camposKey:1043-4666 2012-01-01 Genetic polymorphisms located in TGFB1, AGTR1, and VEGFA genes are associated to chronic renal allograft dysfunction321326, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=23317]], camposKey:1886-2845 2012-01-01 Presentación del XXXIV Congreso Anual de la Sociedad Española de Diálisis y Trasplante, Valladolid 2012460, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61626]], camposKey:0211-6995 2012-01-01 Spanish study of anticoagulation in haemodialysis
Estudio Español sobre anticoagulación en hemodiálisis143152, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43884]], camposKey:0210-6523 2011-01-01 Trasplante renal en el Hospital Clínico de Valladolid6573, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61627]], camposKey:1753-0784 2010-01-01 Effect of long-term steroid withdrawal in renal transplant recipients: A retrospective cohort study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61628]], camposKey:1660-2110 2010-01-01 Evaluation of oxidant-antioxidant balance in patients on maintenance haemodialysis: a comparative study of dialyzers membranes6773, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61590]], camposKey:0902-0063 2009-01-01 A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function2332, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=20596]], camposKey:0211-6995 2008-01-01 Aspectos nutricionales en la insuficiencia renal333342, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61629]], camposKey:0085-2538 2008-01-01 Renal transplantation in the modern immunosuppressive era in Spain: Four-year results from a multicenter database focus on post-transplant cardiovascular disease594599, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61630]], camposKey:1555-9041 2007-01-01 Course of vascular access and relationship with treatment of anemia11631169, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=45728]], camposKey:1886-2845 2007-01-01 Hemodiálisis y enfermedad cardiovascular. Documento de Consenso de la Sociedad Española de Diálisis y Trasplante6572, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61631]], camposKey:0041-1345 2007-01-01 Renal Function in Patients With Cadaveric Kidney Transplants Treated With Tacrolimus or Cyclosporine21672169, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61591]], camposKey:0902-0063 2006-01-01 Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain650658, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61634]], camposKey:0211-139X 2006-01-01 Pharmacovigilance study of the safety and effectiveness of losartan therapy: Long-term effects of losartan alone or in combination on uricemia
Estudio de farmacovigilancia para evaluar la seguridad y la efectividad del tratamiento con losartán: Efectos a largo plazo de losartán solo o en combinación sobre la uricemia1320, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61633]], camposKey:0041-1345 2006-01-01 Posttransplant Diabetes Mellitus in Renal Allograft Recipients: A Prospective Multicenter Study at 2 Years35303532, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61632]], camposKey:0211-6995 2006-01-01 Serum creatinine and creatinine clearance to estimate renal function in essential hypertension
Creatinina sérica y aclaramiento de creatinina para la valoración de la función renal en hipertensos esenciales6473, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61593]], camposKey:0041-1345 2005-01-01 Cystatin C as a marker of renal function in kidney transplant patients38443847, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=45729]], camposKey:1886-2845 2005-01-01 Definición, métodos de evaluación y pautas para la consecución de la calidad en hemodiálisis6172, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=45727]], camposKey:1886-2845 2004-01-01 Eritropoyesis en la insuficiencia renal crónica135148, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43684]], camposKey:1886-2845 2004-01-01 Estudio del perfil lipídico y del grosor íntima--media de la carótida en pacientes en hemodiálisis (HD) tratados con atorvastatina225234, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61604]], camposKey:0931-0509 2004-01-01 The impact of donor age on the results of renal transplantation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61636]], camposKey:0041-1345 2003-01-01 Immunoprophylaxis with Simulect (basiliximab) in kidney transplantation: Results from routine clinical practice at 18 kidney transplant units16911693, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61637]], camposKey:0886-022X 2003-01-01 Isolation, characterization, and evaluation of metallothionein in renal transplant patients719725, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42125]], camposKey:0041-1345 2003-01-01 Study of the activity of glutathione-peroxidase, glutathione-transferase, and glutathione-reductase in renal transplants13461350, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61595]], camposKey:0041-1345 2003-01-01 Tacrolimus-basiliximab versus cyclosporine-basiliximab in renal transplantation "de novo": Acute rejection and complications16941696, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61635]], camposKey:0886-022X 2003-01-01 Verapamil reverts acute renal functional impairment induced by angiotensin II converting enzyme inhibitors727737, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42127]], camposKey:0886-022X 2002-01-01 Antioxidant enzyme determination and a study of lipid peroxidation in renal transplantation353359, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42126]], camposKey:0886-022X 2002-01-01 Glutathione determination and a study of the activity of glutathione-peroxidase, glutathione-transferase, and glutathione-reductase in renal transplants421432, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61638]], camposKey:0211-6995 2002-01-01 Physical activity as modifier of renal function. Historical review
La actividad física como modificadora de la función renal. Revisión histórica1523, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=23322]], camposKey:0210-6523 2000-01-01 Características y seguimiento durante diez años de los trasplantes renales en el servicio de nefrología del hospital universitario de Valladolid201214, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70601]], camposKey:0212-8799 2000-01-01 El acondicionamiento físico aeróbico como modificador de la respuesta hemodinámica renal durante el ejercicio: importancia de las catecolaminas127133, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61586]], camposKey:0085-2538 1999-01-01 Does the dialysis modality modify the oxidative stress in patients on dialysis?360360, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=23318]], camposKey:0213-3717 1999-01-01 El ejercicio fisico aeróbico como posible causa de lesión renal2532, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61639]], camposKey:0886-022X 1999-01-01 Oxidative stress in chronic renal failure155167, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61640]], camposKey:0028-2766 1995-01-01 Purification and analysis of plasmatic components of middle molecular weight in patients with uremic syndrome160167, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61641]], camposKey:0211-6995 1994-01-01 Arterial hypertension in the adolescent. Conventional clinical measurement (CCM) versus continuous monitoring of ambulatory blood pressure data (CMABP)
HIPERTENSION ARTERIAL EN ADOLESCENTES, TOMA CASUAL VS. REGISTRO CONTINUO AMBULATORIO DE LA PRESION ARTERIAL297301, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61642]], camposKey:0212-7113 1993-01-01 Inhibitor effect of albumine and ceruloplasmine on hemolysis induced by aluminium in red blood cells in vitro of hemodyaliced
EFECTO INHIBIDOR DE LA ALBUMINA Y CERULOPLASMINA SOBRE LA HEMOLISIS INDUCIDA POR ALUMINIO EN HEMATIES IN VITRO DE HEMODIALIZADOS139141, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61605]], camposKey:0212-7113 1992-01-01 Hemolysis induction by copper in red blood cells and its inhibition by cystein and cerulplasmin in patients undergoing hemodialysis EFECTO INHIBIDOR DE LA CISTEINA Y CERULOPLASMINA SOBRE RADICALES LIBRES INDUCIDOS POR COBRE EN HEMATIES DE PACIENTES EN HEMODIALISIS (HD)5053, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61643]], camposKey:0378-4835 1992-01-01 Metallic carcinogenesis, tumoral markers and immune response in breast cancer
ELEMENTOS TRAZA, MARCADORES TUMORALES Y RESPUESTA INMUNE EN EL CANCER DE MAMA245252, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=45726]], camposKey:0210-6523 1990-01-01 Aislamiento y caracterización de componentes plasmáticos de peso molecular medio en la uremia1327, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61736]], camposKey:0252-1164 1990-01-01 Comparative analysis of certain metals and tumor markers in bronchopulmonary cancer and colorectal cancers261266, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61644]], camposKey:0378-4835 1990-01-01 Comparative analysis of some metals and tumoral markers in lung and colon cancer451458, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61645]], camposKey:0211-6995 1987-01-01 Biocompatibility of dialysis membranes: Effect on beta-2-microglobulin and complement activation121125, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61646]], camposKey:0014-2565 1983-01-01 Effect on the fat metabolism and on the plasma copper and zinc levels of the D-L carnitine during hemodialysis
ESTUDIO DEL EFECTO SOBRE EL METABOLISMO DE LAS GRASAS, COBRE Y CINC PLASMATICO DE LA D-L CARNITINA EN HEMODIALISIS4143, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61647]], camposKey:0025-7753 1982-01-01 Leptospirosis caused by L. grippotyphosa accompanied by acute renal failure
LEPTOSPIROSIS GRIPOTIFOSA Y FRACASO RENAL AGUDO2831, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61648]], camposKey:0300-5127 1981-01-01 Study of metabolism of insulin, zinc and copper in diabetic patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61606]], camposKey:0014-2565 1981-01-01 Zinc and copper in acute myocardial infarction and its correlation with enzymatic activity Cinc y cobre en el infarto agudo de miocardio y su correlación con la actividad enzimática.153155, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61607]], camposKey:0025-7753 1979-01-01 Dementia and hemodialysis (author's transl) Demencia y hemodiálisis.6164, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61650]], camposKey:0025-7753 1979-01-01 Nephropathy due to analgesics: Interstitial nephritis caused by phenacetin in nine patients
NEFROPATIA POR ANALGESICOS: NEFRITIS INTERSTICIAL POR FENACETINA EN NUEVE PACIENTES277280, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61649]], camposKey:0970-2067 1979-01-01 Serum copper, ceruloplasmin, lactic-dehydrogenase and ¿2-globulin in lung cancer6668, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61651]], camposKey:0028-2766 1978-01-01 Changes in copper and ceruloplasmin in chronic renal insufficiency treated by hemodialysis and peritoneal dialysis312315, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61609]], camposKey:0300-0885 1978-01-01 Serum zinc copper and insulin in diabetes mellitus5658, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61608]], camposKey:0014-2565 1978-01-01 Study of insulinemia and plasma concentration of certain metals in diabetes mellitus Estudio de la insulinemia y de las concentraciones plasmáticas de ciertos metales en la diabetes mellitus.455458, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61611]], camposKey:0014-2565 1977-01-01 Nodular endothoracic sarcoidosis (apropos of a case with biopsy diagnosis) Sarcoidósis nodular endotorácica (a propósito de un caso con comprobación biópsica)307310, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61610]], camposKey:0014-2565 1977-01-01 Serum values of copper, ceruloplasmin and lipids in the aged: comparative study in arteriosclerotic patients Valores séricos de cobre, ceruloplasmina y lípidos en ancianos: estudio comparativo con enfermos arterioscleróticos.2730, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61612]], camposKey:0014-2565 1976-01-01 Hepatic encephalopathy Encefalopatía hepática105112, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61652]], camposKey:0300-0885 1976-01-01 Zinc, copper and ceruloplasmin in arteriosclerosis244245, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61613]], camposKey:0300-0885 1975-01-01 A study of the metabolism of zinc: its metalloenzymes in diabetes mellitus134136, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61614]], camposKey:0014-2565 1975-01-01 Copper, cerulopasmin and zinc in relation to the metabolism of lipids in arteriosclerotic patients Estudio del cobre, ceruloplasma y zinc en relación con el metabolismo de los lípidos en arterioescleróticos243246, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61616]], camposKey:0014-2565 1974-01-01 Increase of urinary excretion of zinc and metallo enzymes in diabetes mellitus HIPERCINCURIA Y METALOENZIMAS EN LA DIABETES MELLITUS313318, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61615]], camposKey:0014-2565 1974-01-01 Myocardiopathies MIOCARDIOPATIAS407415, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61618]], camposKey:0014-2565 1973-01-01 Behavior of zinc metabolism, LDH and blood pH in neoplastic patients El comportamiento del metabolismo del zinc, LDH y pH sanguineo en enfermos neoplásicos.4346, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61619]], camposKey:0014-2565 1973-01-01 Glomerulopathies: Concept, classification, immunohistochemistry, immunopathology GLOMERULOPATIAS: CONCEPTO, CLASIFICACION INMUNOHISTOQUIMICA E INMUNOPATOLOGIA283286, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61617]], camposKey:0036-4355 1973-01-01 Study of the metabolism of zinc, LDH and blood pH in leukaemias and lymphomas. Previous note ESTUDIO DEL METABOLISMO DEL ZINC, LDH Y PH SANGUINEO EN LEUCEMIAS Y LINFOMAS. NOTA PREVIA271276][][][Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=105479],camposKey=84-7762-754-1Carcinogénesis: fundamentos etiológicos del cáncer 1 1997-01-01 Universidad de Valladolid}][][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30853]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145639285]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638177]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145633968]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638726]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636015]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145632738]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=1151373706]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145630283]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145628403]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145627444]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626894]]][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64cac4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64cb0c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64c7f0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64cd7e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64d9d7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64d066, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37326a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64cf64, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37323b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64cf6a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64db31, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64d044, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64d405, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64cdac, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64d2f6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372fa1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64ce35, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372930, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64dbcd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372c20, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64c94c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373021, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372cc9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64cecb, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372c37, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64dadb, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64cec2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64d37f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64cfb4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64cfb3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64c8fc, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372a7e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373039, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d5f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b77, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b5a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64ce5e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64ce3e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64ce40, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64d948, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64cb7b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64d08a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b21, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64ce3d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d7b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b0c][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413e94]][][][][][][][]